Methylphenidate-induced choreoathetosis.
D005260:Female; D006220:Haloperidol / Q000627:therapeutic use; D006801:Humans; D008701:Methapyrilene / Q000009:adverse effects; D008774:Methylphenidate / Q000009:adverse effects*; D008875:Middle Aged; D009069:Movement Disorders / Q000139:chemically induced* / Q000188:drug therapy; D010830:Physostigmine / Q000627:therapeutic use; D011954:Receptors, Dopamine / Q000187:drug effects
D011954:Receptors, Dopamine; D008774:Methylphenidate; D010830:Physostigmine; D008701:Methapyrilene; D006220:Haloperidol